Effect of Latent Human Immunodeficiency Virus Infection on Cell Surface Phenotype
AUTOR(ES)
Brooks, David G.
FONTE
American Society for Microbiology
RESUMO
Highly active antiretroviral therapy has succeeded in many cases in suppressing virus production in patients infected with human immunodeficiency virus (HIV); however, once treatment is discontinued, virus replication is rekindled. One reservoir capable of harboring HIV in a latent state and igniting renewed infection once therapy is terminated is a resting T cell. Due to the sparsity of T cells latently infected with HIV in vivo, it has been difficult to study viral and cellular interactions during latency. The SCID-hu (Thy/Liv) mouse model of HIV latency, however, provides high percentages of latently infected cells, allowing a detailed analysis of phenotype. Herein we show that latently infected cells appear phenotypically normal. Following cellular stimulation, the virus completes its life cycle and induces phenotypic changes, such as CD4 and major histocompatibility complex class I down-regulation, in the infected cell. In addition, HIV expression following activation did not correlate with expression of the cellular activation marker CD25. The apparently normal phenotype and lack of HIV expression in latently infected cells could prevent recognition by the immune response and contribute to the long-lived nature of this reservoir.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=135922Documentos Relacionados
- Interleukin-7 Induces Expression of Latent Human Immunodeficiency Virus Type 1 with Minimal Effects on T-Cell Phenotype
- Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo.
- Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus.
- High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants.
- Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection.